| Control group | Agonist group | Antagonist group |
---|---|---|---|
Sample size | 15 | 11 | 15 |
Age (years) | 31.3 ± 2.66 | 30.9 ± 2.91 | 31.0 ± 2.90 |
Body mass index | 22.8 ± 3.46 | 21.3 ± 1.48 | 21.9 ± 3.06 |
Stimulation duration (day) | / | 10.8 ± 1.47 | 9.33 ± 0.98* |
Total Gn dose (IU) | / | 2178.41 ± 465.8 | 2125 ± 527.23 |
Total Cetrorelex dose (mg) | / | / | 1.3 ± 0.25 |
E2 on trigger day (pg/ml) | 241.13 ± 69.55* | 4180.27 ± 1282.49 | 4095.4 ± 1351.49 |
P on trigger day (ng/ml) | 1.39 ± 0.52 | 1.38 ± 0.42 | 1.24 ± 0.36 |
LH on trigger day (U/L) | / | 1.64 ± 0.92 | 2.21 ± 1.57 |
Number of oocytes retrieved | / | 10.82 ± 3.06 | 10.2 ± 2.75 |
Endometrial thickness on biopsy day (cm) | 0.86 ± 0.10 | 0.94 ± 0.19 | 0.92 ± 0.17 |
P on biopsy day (ng/ml) | 18.7 ± 4.12 | 19.36 ± 4.56 | 19.97 ± 3.66 |